If you are interested in learning more about one of our ongoing clinical trials, please feel free to call our Clinical Research Program at 520-320-2147.
Alzheimer’s Disease Clinical Trial – Now Enrolling
Early Alzheimer’s Disease: Genentech GRADUATE Study
This study is comparing the effects of an investigational drug versus placebo on participants and their memory problems.
Multiple Sclerosis Clinical Trial – Now Enrolling
Multiple Sclerosis Study: Novartis PASSAGE Study
The PASSAGE study is a long-term study monitoring safety in patients newly started on pharmaceutical therapy for MS.
Glioblastoma Clinical Trial – Now Enrolling
Glioblastoma Study: Nativis VOYAGER
This feasibility study will assess the effects of the Nativis Voyager therapy in patients newly diagnosed with GBM (Glioblastoma Multiforme). The study will enroll and treat up to 11 subjects and will be combined with standard of care radiotherapy and temozolomide.
Glioblastoma Clinical Trial – Now Enrolling
Recurrent Glioblastoma: Boston Biomedical Wizard Study
This study will help us learn more about a newly discovered vaccine drug that is being tested in people with recurrent or progressive glioblastoma, who have already received treatment.
Glioblastoma Clinical Trial – Now Enrolling
Recurrent and Newly Diagnosed Glioblastoma: BeiGene BGB-290 Study
This study is to evaluate the safety, efficacy and clinical activity of BGB-290 in combination with radiation therapy (RT) and/or temozolomide (TMZ) in subjects with newly diagnosed or recurrent/refractory glioblastoma.
Learn more at ClinicalTrials
Identifier (NCT): NCT03276286
Site Director, Clinical Research Program
Our research site director is a Registered Nurse and a Certified Clinical Research Professional with many years of experience managing and coordinating clinical trials. For more information regarding our studies, please contact Marjorie Pazzi at (520) 320-2147.